Trial
NCT00875875
Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Travelers' Diarrhea
Intervention
Rifaximin
Why stopped
No study population in Mexico (H1N1). Study withdrawn from IRB consideration.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-10